Seeing Is Believing
Healthcare - Sector
Caladrius Biosciences's activity chart (see below) currently has 4 price targets and 7 ratings on display.
Most recent stock forecast was given by from HC WAINWRIGHT on 06-Jun-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Nov-2018
4 years 3 months 29 days ago
(06-Jun-2022)
0/2 (0%)
$13.85 (297.85%)
Buy Since 20-Nov-2018
$18.5
4 years 6 months 12 days ago
(23-Mar-2022)
0/2 (0%)
$14.07 (317.61%)
Buy Since 22-May-2020
$7
$6.57 (1527.91%)
$7
5 years 7 months 2 days ago
(03-Mar-2021)
0/2 (0%)
$5.1 (268.42%)
Buy Since 15-Mar-2019
$6
$5.57 (1295.35%)
7 years 6 months 20 days ago
(15-Mar-2019)
0/1 (0%)
$2.08 (53.06%)
Which analyst most recently updated their price target on CLBS (Caladrius Biosciences)?
Which analyst has the most public recommendations on CLBS (Caladrius Biosciences)?
Which analyst is the currently most bullish on CLBS (Caladrius Biosciences)?
Which analyst is the currently most reserved on CLBS (Caladrius Biosciences)?